Qingfeng Chen

Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 24

Top Topics

Plasmodium Falciparum

Multiple Myeloma

Top Venues

Nature communications

Cancer research communications

This page only lists publications with an associated author ORCID identifier.

Publications

Daniel Aron Ang, Jean-Michel Carter, Kamalakshi Deka, Joel H L Tan, Jianbiao Zhou, Qingfeng Chen, Wee Joo Chng, Nathan Harmston, Yinghui Li
Aberrant non-canonical NF-κB signalling reprograms the epigenome landscape to drive oncogenic transcriptomes in multiple myeloma. Nature communications 15 (1) (2024)
Daniel Aron Ang, Jean-Michel Carter, Kamalakshi Deka, Joel H L Tan, Jianbiao Zhou, Qingfeng Chen, Wee Joo Chng, Nathan Harmston, Yinghui Li
Aberrant non-canonical NF-κB signalling reprograms the epigenome landscape to drive oncogenic transcriptomes in multiple myeloma. Nature communications 15 (1) (2024)
Wei-Xiang Sin, Narendra Suhas Jagannathan, Denise Bei Lin Teo, Faris Kairi, Shin Yie Fong, Joel Heng Loong Tan, Dedy Sandikin, Ka-Wai Cheung, Yen Hoon Luah, Xiaolin Wu, Joshua Jebaraj Raymond, Francesca Lorraine Wei Inng Lim, Yie Hou Lee, Michaela Su-Fern Seng, Shui Yen Soh, Qingfeng Chen, Rajeev J Ram, Lisa Tucker-Kellogg, Michael E Birnbaum
A high-density microfluidic bioreactor for the automated manufacturing of CAR T cells. Nature biomedical engineering (2024)
Daniel Aron Ang, Jean-Michel Carter, Kamalakshi Deka, Joel H L Tan, Jianbiao Zhou, Qingfeng Chen, Wee Joo Chng, Nathan Harmston, Yinghui Li
Aberrant non-canonical NF-κB signalling reprograms the epigenome landscape to drive oncogenic transcriptomes in multiple myeloma. Nature communications 15 (1) (2024)
Siok Ping Yeo, Lindsay Kua, Jin Wei Tan, Joanna Kristyn Lim, Fiona Hs Wong, May Delos Santos, Chek-Meng Poh, Angeline Xh Goh, Xin Yu Koh, Xiaohua Zhou, Ravisankar Rajarethinam, Qingfeng Chen, Zhisheng Her, Ivan D Horak, Lionel Low, Kar Wai Tan
B7-H3-Targeting Chimeric Antigen Receptors Epstein Barr Virus Specific T Cells Provides a Tumor Agnostic Off-The-Shelf Therapy Against B7-H3 Positive Solid Tumors. Cancer research communications (2024)
Ki Hyun Bae, Fritz Lai, Qingfeng Chen, Motoichi Kurisawa
Potentiating Gilteritinib Efficacy Using Nanocomplexation with a Hyaluronic Acid-Epigallocatechin Gallate Conjugate. Polymers 16 (2) (2024)
Siok Ping Yeo, Lindsay Kua, Jin Wei Tan, Joanna Kristyn Lim, Fiona Hs Wong, May Delos Santos, Chek-Meng Poh, Angeline Xh Goh, Xin Yu Koh, Xiaohua Zhou, Ravisankar Rajarethinam, Qingfeng Chen, Zhisheng Her, Ivan D Horak, Lionel Low, Kar Wai Tan
B7-H3-Targeting Chimeric Antigen Receptors Epstein-Barr Virus-specific T Cells Provides a Tumor Agnostic Off-The-Shelf Therapy Against B7-H3-positive Solid Tumors. Cancer research communications 4 (6) (2024)
Siok Ping Yeo, Lindsay Kua, Jin Wei Tan, Joanna Kristyn Lim, Fiona Hs Wong, May Delos Santos, Chek-Meng Poh, Angeline Xh Goh, Xin Yu Koh, Xiaohua Zhou, Ravisankar Rajarethinam, Qingfeng Chen, Zhisheng Her, Ivan D Horak, Lionel Low, Kar Wai Tan
B7-H3-Targeting Chimeric Antigen Receptors Epstein-Barr Virus-specific T Cells Provides a Tumor Agnostic Off-The-Shelf Therapy Against B7-H3-positive Solid Tumors. Cancer research communications 4 (6) (2024)
Ki Hyun Bae, Fritz Lai, Qingfeng Chen, Motoichi Kurisawa
Potentiating Gilteritinib Efficacy Using Nanocomplexation with a Hyaluronic Acid-Epigallocatechin Gallate Conjugate. Polymers 16 (2) (2024)
Ki Hyun Bae, Fritz Lai, Qingfeng Chen, Motoichi Kurisawa
Potentiating Gilteritinib Efficacy Using Nanocomplexation with a Hyaluronic Acid-Epigallocatechin Gallate Conjugate. Polymers 16 (2) (2024)
Isha Karnik, Zhisheng Her, Shu Hui Neo, Wai Nam Liu, Qingfeng Chen
Emerging Preclinical Applications of Humanized Mouse Models in the Discovery and Validation of Novel Immunotherapeutics and Their Mechanisms of Action for Improved Cancer Treatment. Pharmaceutics 15 (6) (2023)
Maxine S Y Lam, Jose Antonio Reales-Calderon, Jin Rong Ow, Joey J Y Aw, Damien Zhi Ming Tan, Ragavi Vijayakumar, Erica Ceccarello, Tommaso Tabaglio, Yan Ting Lim, Wang Loo Chien, Fritz Lai, Anthony Tan Tanoto, Qingfeng Chen, Radoslaw Mikolaj Sobota, Giulia Adriani, Antonio Bertoletti, Ernesto Guccione, Andrea Pavesi
G9a/GLP inhibition during ex vivo lymphocyte expansion increases in vivo cytotoxicity of engineered T cells against hepatocellular carcinoma. Nature communications 14 (1) (2023)
Huey Yee Teo, Haiyan Liu, Kylie Su Mei Yong, Yonghao Liu, Yu Mei, Zuhairah Binte Hanafi, Ying Zhu, Yen Leong Chua, Nicholas R J Gascoigne, Qingfeng Chen, Haiyan Liu
IL12/18/21 pre-activation enhances the anti-tumor efficacy of expanded γδT cells and overcomes resistance to anti-PD-L1 treatment. Cancer immunology research (2023)
Maxine S Y Lam, Jose Antonio Reales-Calderon, Jin Rong Ow, Joey J Y Aw, Damien Zhi Ming Tan, Ragavi Vijayakumar, Erica Ceccarello, Tommaso Tabaglio, Yan Ting Lim, Wang Loo Chien, Fritz Lai, Anthony Tan Tanoto, Qingfeng Chen, Radoslaw Mikolaj Sobota, Giulia Adriani, Antonio Bertoletti, Ernesto Guccione, Andrea Pavesi
G9a/GLP inhibition during ex vivo lymphocyte expansion increases in vivo cytotoxicity of engineered T cells against hepatocellular carcinoma. Nature communications 14 (1) (2023)
Maxine S Y Lam, Jose Antonio Reales-Calderon, Jin Rong Ow, Joey J Y Aw, Damien Zhi Ming Tan, Ragavi Vijayakumar, Erica Ceccarello, Tommaso Tabaglio, Yan Ting Lim, Wang Loo Chien, Fritz Lai, Anthony Tan Tanoto, Qingfeng Chen, Radoslaw Mikolaj Sobota, Giulia Adriani, Antonio Bertoletti, Ernesto Guccione, Andrea Pavesi
G9a/GLP inhibition during ex vivo lymphocyte expansion increases in vivo cytotoxicity of engineered T cells against hepatocellular carcinoma. Nature communications 14 (1) (2023)
Isha Karnik, Zhisheng Her, Shu Hui Neo, Wai Nam Liu, Qingfeng Chen
Emerging Preclinical Applications of Humanized Mouse Models in the Discovery and Validation of Novel Immunotherapeutics and Their Mechanisms of Action for Improved Cancer Treatment. Pharmaceutics 15 (6) (2023)
Maxine S Y Lam, Jose Antonio Reales-Calderon, Jin Rong Ow, Joey J Y Aw, Damien Zhi Ming Tan, Ragavi Vijayakumar, Erica Ceccarello, Tommaso Tabaglio, Yan Ting Lim, Wang Loo Chien, Fritz Lai, Anthony Tan Tanoto, Qingfeng Chen, Radoslaw Mikolaj Sobota, Giulia Adriani, Antonio Bertoletti, Ernesto Guccione, Andrea Pavesi
G9a/GLP inhibition during ex vivo lymphocyte expansion increases in vivo cytotoxicity of engineered T cells against hepatocellular carcinoma. Nature communications 14 (1) (2023)
Maxine S Y Lam, Jose Antonio Reales-Calderon, Jin Rong Ow, Joey J Y Aw, Damien Zhi Ming Tan, Ragavi Vijayakumar, Erica Ceccarello, Tommaso Tabaglio, Yan Ting Lim, Wang Loo Chien, Fritz Lai, Anthony Tan Tanoto, Qingfeng Chen, Radoslaw Mikolaj Sobota, Giulia Adriani, Antonio Bertoletti, Ernesto Guccione, Andrea Pavesi
G9a/GLP inhibition during ex vivo lymphocyte expansion increases in vivo cytotoxicity of engineered T cells against hepatocellular carcinoma. Nature communications 14 (1) (2023)
Wai Nam Liu, Wing Yan So, Sarah L Harden, Shin Yie Fong, Melissa Xin Yu Wong, Wilson Wei Sheng Tan, Sue Yee Tan, Jessica Kai Lin Ong, Ravisankar Rajarethinam, Min Liu, Jia Ying Cheng, Lisda Suteja, Joe Poh Sheng Yeong, N Gopalakrishna Iyer, Darren Wan-Teck Lim, Qingfeng Chen
Successful targeting of PD-1/PD-L1 with chimeric antigen receptor-natural killer cells and nivolumab in a humanized mouse cancer model. Science advances 8 (47) (2022)
Shijun Ma, Yue Zhao, Wee Chyan Lee, Li-Teng Ong, Puay Leng Lee, Zemin Jiang, Gokce Oguz, Zhitong Niu, Min Liu, Jian Yuan Goh, Wenyu Wang, Matias A Bustos, Sidse Ehmsen, Adaikalavan Ramasamy, Dave S B Hoon, Henrik Jørn Ditzel, Ern Yu Tan, Qingfeng Chen, Qiang Yu
Hypoxia induces HIF1α-dependent epigenetic vulnerability in triple negative breast cancer to confer immune effector dysfunction and resistance to anti-PD-1 immunotherapy. Nature communications 13 (1) (2022)
Marvin Chew, Weijian Ye, Radoslaw Igor Omelianczyk, Charisse Flerida A Pasaje, Regina Hoo, Qingfeng Chen, Jacquin C Niles, Jianzhu Chen, Peter Rainer Preiser
Selective expression of variant surface antigens enables Plasmodium falciparum to evade immune clearance in vivo. Nature communications 13 (1) (2022)
Li-Teng Ong, Wee Chyan Lee, Shijun Ma, Gokce Oguz, Zhitong Niu, Yi Bao, Mubaraka Yusuf, Puay Leng Lee, Jian Yuan Goh, Panpan Wang, Kylie Su Mei Yong, Qingfeng Chen, Wenyu Wang, Adaikalavan Ramasamy, Dave S B Hoon, Henrik Jørn Ditzel, Ern Yu Tan, Soo Chin Lee, Qiang Yu
IFI16-dependent STING signaling is a crucial regulator of anti-HER2 immune response in HER2+ breast cancer. Proceedings of the National Academy of Sciences of the United States of America 119 (31) (2022)
Raghav Sundar, Kie Kyon Huang, Vikrant Kumar, Kalpana Ramnarayanan, Deniz Demircioglu, Zhisheng Her, Xuewen Ong, Zul Fazreen Bin Adam Isa, Manjie Xing, Angie Lay-Keng Tan, David Wai Meng Tai, Su Pin Choo, Weiwei Zhai, Jia Qi Lim, Meghna Das Thakur, Luciana Molinero, Edward Cha, Marcella Fasso, Monica Niger, Filippo Pietrantonio, Jeeyun Lee, Anand D Jeyasekharan, Aditi Qamra, Radhika Patnala, Arne Fabritius, Mark De Simone, Joe Yeong, Cedric Chuan Young Ng, Sun Young Rha, Yukiya Narita, Kei Muro, Yu Amanda Guo, Anders Jacobsen Skanderup, Jimmy Bok Yan So, Wei Peng Yong, Qingfeng Chen, Jonathan Göke, Patrick Boon-Ooi Tan
Epigenetic promoter alterations in GI tumour immune-editing and resistance to immune checkpoint inhibition. Gut (2021)
Mandeep Kaur, Adam C Drake, Guangan Hu, Stephen Rudnick, Qingfeng Chen, Ryan Phennicie, Ricardo M Attar, Jeffrey Nemeth, Francois Gaudet, Jianzhu Chen
Induction and Therapeutic Targeting of Human NPM1c+ Myeloid Leukemia in the Presence of Autologous Immune System in Mice. Journal of immunology (Baltimore, Md. : 1950) 202 (6) (2019)